Aug 29, 2024 06:14AM
Aug 28, 2024 08:59PM
Aug 21, 2024 09:00AM
Jul 31, 2024 10:15AM
Feb 19, 2024 09:00AM
Sep 26, 2023 09:01AM
Sep 26, 2023 09:00AM GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development
Aug 31, 2023 09:00AM
Jul 26, 2023 09:00AM
Jul 24, 2023 09:01AM
Jul 24, 2023 09:00AM
Jul 20, 2023 09:02AM
Jul 20, 2023 09:00AM
Jul 10, 2023 09:00AM GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference
Jun 28, 2023 09:00AM
Jun 27, 2023 10:19AM
Jun 27, 2023 10:15AM
May 31, 2023 09:07AM
May 31, 2023 09:00AM
May 25, 2023 09:00AM
May 24, 2023 08:04AM Geovax Labs's (GOVX) Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
May 24, 2023 08:00AM
May 15, 2023 09:00AM
May 9, 2023 09:00AM
May 4, 2023 04:00PM
Apr 26, 2023 09:00AM
Apr 25, 2023 09:00AM
Apr 17, 2023 09:04AM Geovax Labs Inc. (GOVX) Announces Expansion of Next-Generation COVID-19 Vaccine Rights to Include Omicron Variants and Use Against Orthopoxviruses
Apr 17, 2023 09:00AM
Apr 6, 2023 10:00AM
Apr 5, 2023 01:30PM
Apr 5, 2023 01:30PM
Mar 30, 2023 11:00AM
Mar 23, 2023 04:00PM
Mar 15, 2023 09:00AM GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine Industry Excellence Award at World Vaccine Congress
Mar 9, 2023 09:00AM
Mar 6, 2023 09:00AM
Feb 27, 2023 09:00AM
Feb 15, 2023 09:01AM
Feb 15, 2023 09:00AM
Feb 8, 2023 09:00AM
Feb 7, 2023 09:05AM Geovax Labs Inc. (GOVX) Expands Gedeptin Clinical Research for Advanced Head and Neck Cancers
Feb 7, 2023 09:00AM
Jan 26, 2023 09:00AM
Jan 25, 2023 11:01AM
Jan 25, 2023 11:00AM
Jan 4, 2023 09:00AM
Dec 20, 2022 09:00AM
Dec 7, 2022 04:00PM Geovax Labs Inc. (GOVX) Appoints Jayne Morgan, M.D., to its Board of Directors
Dec 7, 2022 04:00PM

66,450 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All